Pasithea Therapeutics Corp Stock Statistic Functions Beta

KTTA Stock  USD 3.10  0.08  2.52%   
Pasithea Therapeutics statistic functions tool provides the execution environment for running the Beta function and other technical functions against Pasithea Therapeutics. Pasithea Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of statistic functions indicators. As with most other technical indicators, the Beta function function is designed to identify and follow existing trends. Pasithea Therapeutics statistical functions help analysts to determine different price movement patterns based on how price series statistical indicators change over time. Please specify Time Period to run this model.

The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Pasithea Therapeutics correlated with the market. If Beta is less than 0 Pasithea Therapeutics generally moves in the opposite direction as compared to the market. If Pasithea Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pasithea Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pasithea Therapeutics is generally in the same direction as the market. If Beta > 1 Pasithea Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.

Pasithea Therapeutics Technical Analysis Modules

Most technical analysis of Pasithea Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Pasithea from various momentum indicators to cycle indicators. When you analyze Pasithea charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Pasithea Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pasithea Therapeutics Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pasithea Therapeutics Corp based on widely used predictive technical indicators. In general, we focus on analyzing Pasithea Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pasithea Therapeutics's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Pasithea Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Pasithea Therapeutics, we also check how macroeconomic factors affect Pasithea Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2010 2022 2023 (projected)
PB Ratio203.230.380.4
Capex To Depreciation15.5966.065.3E-5
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pasithea Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.153.0612.42
Details
Intrinsic
Valuation
LowRealHigh
0.122.4911.85
Details
Naive
Forecast
LowNextHigh
0.052.6912.06
Details
1 Analysts
Consensus
LowTargetHigh
1.822.002.22
Details

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Pasithea Therapeutics is a strong investment it is important to analyze Pasithea Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pasithea Therapeutics' future performance. For an informed investment choice regarding Pasithea Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pasithea Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pasithea Therapeutics. If investors know Pasithea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pasithea Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(14.79)
Revenue Per Share
0.37
Quarterly Revenue Growth
14.981
Return On Assets
(0.38)
Return On Equity
(0.63)
The market value of Pasithea Therapeutics is measured differently than its book value, which is the value of Pasithea that is recorded on the company's balance sheet. Investors also form their own opinion of Pasithea Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Pasithea Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pasithea Therapeutics' market value can be influenced by many factors that don't directly affect Pasithea Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pasithea Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pasithea Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pasithea Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.